Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO
Life Sciences Jobs ... Source: BioSpace
BeyondSpring Chief Medical Officer To Present Clinical Data For Lead Asset Plinabulin At 2017 BIO International Convention In San Diego
Life Sciences Jobs ... Source: BioSpace
Connecticut Compounder Warned on Unsanitary Conditions and More
Beacon Prescriptions, a compounding pharmacy in Southington, Conn., was warned by the FDA for unsanitary conditions and other federal violations, according to a letter sent earlier this month. Source: Drug…
Stratus, Sonar Shut Down by Federal Judge
A federal district judge shut down drugmaker Stratus Pharmaceuticals in Florida and distributor Sonar Products of New Jersey with a permanent injunction Thursday. Source: Drug Industry Daily
NICE to Recommend Kadcyla, Kyprolis for NHS Funding; But Rejects Besponsa Coverage Before EU Approval
The U.K. is planning to move Roche’s Kadcyla (trastuzumab emtansine) into the NHS’s routine funding programs later this summer, following guidance from the National Institute for Health and Care Excellence…
PTAB to Review Blockbuster Cialis, Prevnar Patents
The PTO’s Patent Trial and Appeal Board said it will review patents covering the blockbuster erectile dysfunction drug Cialis and a widely used pneumonia vaccine, Prevnar 13, granting petitions from…
What Biogen CFO's Departure Means for Company's M&A Strategy
<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x470-biogen.jpg" NAME"What Biogen CFO's Departure Means for Company's M&A Strategy" ALT"What Biogen CFO's Departure Means for Company's M&A Strategy"June 15, 2017By Mark Terry, BioSpace.com Breaking News StaffEverybody... Source: BioSpace
- Go to the previous page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- …
- 33
- Go to the next page